Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$0.24 - $0.52 $318,833 - $690,804
1,328,471 Added 74.4%
3,114,098 $1.06 Million
Q4 2022

Feb 13, 2023

BUY
$0.22 - $1.04 $55,905 - $264,279
254,115 Added 16.59%
1,785,627 $464,000
Q3 2022

Nov 14, 2022

SELL
$0.25 - $2.4 $1,915 - $18,386
-7,661 Reduced 0.5%
1,531,512 $1.34 Million
Q2 2022

Aug 12, 2022

BUY
$1.22 - $3.05 $1.57 Million - $3.92 Million
1,286,748 Added 509.75%
1,539,173 $1.94 Million
Q1 2022

May 13, 2022

SELL
$2.64 - $4.67 $18,321 - $32,409
-6,940 Reduced 2.68%
252,425 $775,000
Q4 2021

Feb 08, 2022

BUY
$4.4 - $8.8 $167,248 - $334,496
38,011 Added 17.17%
259,365 $1.16 Million
Q3 2021

Nov 15, 2021

BUY
$7.44 - $13.99 $1.65 Million - $3.1 Million
221,354 New
221,354 $1.68 Million

Others Institutions Holding SMFR

About Sema4 Holdings Corp.


  • Ticker SMFR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 380,641,984
  • Market Cap $129M
  • Description
  • Sema4 Holdings Corp., doing business as Sema4, operates as a health information company that enhances diagnosis, treatment, and prevention of disease through data. The company provides Centrellis, an AI-driven health intelligence platform that delivers comprehensive insights to biopharma to accelerate the drug discovery, development, and commerc...
More about SMFR
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.